| 000 | 01529 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513234018.0 | ||
| 264 | 0 | _c20010405 | |
| 008 | 200104s 0 0 eng d | ||
| 022 | _a0934-0874 | ||
| 024 | 7 |
_a10.1111/j.1432-2277.1994.tb01303.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aUndre, N | |
| 245 | 0 | 0 |
_aPharmacokinetic interpretation of FK 506 levels in blood and in plasma during a European randomised study in primary liver transplant patients. The FK 506 European Study Group. _h[electronic resource] |
| 260 |
_bTransplant international : official journal of the European Society for Organ Transplantation _c1994 |
||
| 300 |
_aS15-21 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aBlood Proteins _xmetabolism |
| 650 | 0 | 4 |
_aCreatinine _xanalysis |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aLiver Transplantation _ximmunology |
| 650 | 0 | 4 |
_aSerum Albumin _xanalysis |
| 650 | 0 | 4 |
_aTacrolimus _xadverse effects |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aMöller, A | |
| 773 | 0 |
_tTransplant international : official journal of the European Society for Organ Transplantation _gvol. 7 Suppl 1 _gp. S15-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1432-2277.1994.tb01303.x _zAvailable from publisher's website |
| 999 |
_c11207329 _d11207329 |
||